Agency Forms Undergoing Paperwork Reduction Act Review
Published Date: 6/26/2026
Notice
Summary
The CDC is asking for public feedback on a new form they want to use for health surveys. They’re making sure the form is useful, clear, and easy to fill out, and they want to keep the time and cost low for everyone involved. You’ve got 30 days to share your thoughts before the government gives the final thumbs-up!
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-19766, Proposed Data Collection Submitted for Public Comment and Recommendations
The CDC wants to keep collecting info about its Colorectal Cancer Control Program to help fight cancer better. They’re asking the public and other agencies to share thoughts by November 27, 2026. This ongoing data collection involves surveys and reports from clinics, aiming to improve health outcomes without adding extra costs.
2026-19170, Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for your thoughts on their STI Surveillance Network forms to make sure they’re useful and not too much work. If you have ideas on how to improve or simplify these forms, now’s your chance to speak up within 30 days. This helps keep data collection smart and efficient without wasting time or money.
2026-18948, Order Under Sections 362 and 365 of the Public Health Service Act Continuing the Suspension of the Right To Introduce Certain Persons From Countries Where a Quarantinable Communicable Disease Exists
The CDC is keeping a rule that stops some people from entering the U.S. if they've been in countries with serious contagious diseases. This rule started on September 11, 2026, and will last until October 11, 2026, unless changed earlier. It helps protect public health by limiting disease spread, and the CDC is asking for public comments by October 1, 2026.
2026-18901, World Trade Center Health Program; Petition 048a-Peripheral Artery Disease; Finding of Insufficient Evidence
The World Trade Center Health Program reviewed a request to add peripheral artery disease to its list of covered health conditions but found there isn’t enough proof to do so right now. This means firefighters and rescue workers won’t see changes to their benefits for this condition at this time. The decision was made official on September 15, 2026, with no new costs or coverage updates planned.
2026-18900, World Trade Center Health Program; Petitions 048 and 051a-Stroke; Finding of Insufficient Evidence
The World Trade Center Health Program reviewed requests to add stroke as a covered health condition but found there isn’t enough proof to do so right now. This means firefighters, law enforcement, and others exposed at the WTC won’t see stroke added to their benefits list yet. The decision was made official on September 15, 2026, with no changes to coverage or costs at this time.
2026-18745, Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for public feedback on a new form to help track and monitor travelers for Ebola in 2026. They want to make sure the form is useful, clear, and not too much work for people to fill out. Comments are open for 30 days, so anyone affected or interested should share their thoughts soon!
Previous / Next Documents
Previous: 2026-12957, Sunshine Act Meetings; Correction
The Postal Service fixed some missing details about their Board of Governors meeting on May 8, 2026. They clarified the exact times, location, and what topics will be covered during the closed morning session and the open afternoon session. This update helps everyone stay in the loop with no extra costs or delays.
Next: 2026-12959, Determination That Prednisolone Tablet, 5 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that the 5 mg prednisolone tablet wasn’t taken off the market because of safety or effectiveness problems. This means generic drug makers can keep getting approval to sell their versions of this medicine, as long as they follow the rules. Patients and pharmacies can expect continued access to affordable generics without any interruptions or extra costs.